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Abstract
Purpose: Accurate delineation of the prostate gland and intraprostatic lesions (ILs) is essential for prostate cancer dose-escalated
radiation therapy. The aim of this study was to develop a sophisticated deep neural network approach to magnetic resonance image
analysis that will help IL detection and delineation for clinicians.
Methods and Materials: We trained and evaluated mask region-based convolutional neural networks to perform the prostate gland and
IL segmentation. There were 2 cohorts in this study: 78 public patients (cohort 1) and 42 private patients from our institution (cohort 2).
Prostate gland segmentation was performed using T2-weighted images (T2WIs), although IL segmentation was performed using T2WIs
and coregistered apparent diffusion coefﬁcient maps with prostate patches cropped out. The IL segmentation model was extended to
select 5 highly suspicious volumetric lesions within the entire prostate.
Results: The mask region-based convolutional neural networks model was able to segment the prostate with dice similarity coefﬁcient
(DSC) of 0.88  0.04, 0.86  0.04, and 0.82  0.05; sensitivity (Sens.) of 0.93, 0.95, and 0.95; and speciﬁcity (Spec.) of 0.98, 0.85,
and 0.90. However, ILs were segmented with DSC of 0.62  0.17, 0.59  0.14, and 0.38  0.19; Sens. of 0.55  0.30, 0.63  0.28,
and 0.22  0.24; and Spec. of 0.974  0.010, 0.964  0.015, and 0.972  0.015 in public validation/public testing/private testing
patients when trained with patients from cohort 1 only. When trained with patients from both cohorts, the values were as follows: DSC
of 0.64  0.11, 0.56  0.15, and 0.46  0.15; Sens. of 0.57  0.23, 0.50  0.28, and 0.33  0.17; and Spec. of 0.980  0.009, 0.969
 0.016, and 0.977  0.013.
Conclusions: Our research framework is able to perform as an end-to-end system that automatically segmented the prostate gland and
identiﬁed and delineated highly suspicious ILs within the entire prostate. Therefore, this system demonstrated the potential for assisting
the clinicians in tumor delineation.
 2020 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction

Methods and Materials

Prostate cancer (PCa) is the most common cancer in men
in the United Stated,1 with an estimated 174,650 new cases
and 31,620 deaths expected in 2019.2 Radiation therapy
(RT) is an effective form of prostate cancer (PCa) treatment
and is considered one of the standard treatment options
available. Current practice treats the entire prostate with a
homogeneous dose distribution.3,4 Dose-escalated RT has
been shown to improve biochemical progression-free survival at the expense of increased acute and late toxicities.5
However, using simultaneous boost technique that limits
the volume of dose-escalation to intraprostatic lesions (ILs)
may allow for improved dosimetry with a potential to
improve the therapeutic ratio as well. A median dose to the
entire gland could prevent disease recurrence in the prostate
from satellite tumors and signiﬁcantly reduce the side effects associated with escalated radiation dose to the entire
gland. A boosting dose to the ILs can maintain the effectiveness of focal therapy to treat the ILs that are the main
determinants of tumor progression and prognosis. For this
strategy to be successful, the key requirements included the
ability to accurately and reliably identify clinically significant tumors within the prostate gland.
Malignant ILs can be identiﬁed on magnetic resonance
imaging and are known to correlate with tumor
aggressiveness. Multiparametric magnetic resonance
imaging (mp-MRI) combines anatomic T1- and T2weighted imaging (T2WI) with diffusion-weighted
(DWI) and perfusion-weighted sequences and plays an
essential role in the diagnosis, risk stratiﬁcation, staging,
and treatment guidance in PCa.6 Over the decades,
signiﬁcant advancements have been made in image
acquisition technologies (including mp-magnetic
resonance imaging [MRI]). These allowed for the visualization of not only structural anatomy but also vascular
and functional properties of the prostate gland. However,
the large amount of data has hindered the reproducibility
and efﬁcacy of image interpretation.7 In addition, interobserver variability and clinician fatigue8 can restrict
accurate interpretations before therapeutic interventions.
Therefore, computer-aided diagnostic systems have been
established to help improve clinical practice with MRIbased automated prostate and IL segmentation.
Recent progress in image segmentation has involved
convolutional neural network (CNN) based models. Many
segmentation models fall into 2 classes. The ﬁrst class
does not rely on the region proposal algorithm. U-Net,9
for example, is a classic model widely used in biomedical image segmentation tasks. The underlying
fundamentals of the second class rely on region proposals
such as the mask region-based CNN (Mask R-CNN)
model. It is widely used in semantic segmentation, object
localization, and instance segmentation of natural
images.10

Patient cohorts
A total of 120 patients were divided into 2 cohorts in
this study. Cohort 1 (public patients) included 78
randomly selected patients from the International Society
for Optics and Photonics-American Association of
Physicists in Medicine-National Cancer Institute Prostate
MR Gleason Grade Group Challenge (PROSTATEx-2
Challenge), which is a data set of prostate MRI studies
conducted by American Association of Physicists in
Medicine along with the International Society for Optics
and Photonics and the National Cancer Institute.11e13
Each patient was read under the supervision of an
expert radiologist with more than 20 years of experience.
Areas of suspicion were indicated by the radiologist using
a point marker. Then MR-guided biopsy was followed in
the suspicious area. Conﬁrmation scans were performed
with biopsy needle in situ to conform the accurate localization. Images were acquired on 2 types of Siemens 3
Tesla MR scanners, the MAGNETOM Trio and Skyra.
Axial T2WIs were acquired using a turbo spin echo
sequence with a resolution of around 0.5 mm in plane and
slice thickness of 3.6 mm. Axial DWI sequences were
acquired using a single-shot echo planar imaging
sequence with a resolution of 2 mm in plane and 3.6 mm
slice thickness and with diffusion-encoding gradients in 3
directions. Three b-values were acquired (50, 400, and
800 s/mm2), and the apparent diffuse coefﬁcient (ADC)
map was calculated using the scanner software. All images were acquired without an endorectal coil. Each patient from cohort 1 was proved to have only one lesion.
Cohort 2 (private patients) included 42 patients who
underwent mp-MRI scans at our institution. A transrectal
ultrasound-guided ﬁne-needle biopsy was performed to
conﬁrm the presence of PCa. All images were acquired
using a 3 Tesla MR scanner (Ingenia; Philips Medical
System, Best, the Netherlands). Axial T2WIs were
obtained using fast spin echo (TE/TR: 4389/110 ms, ﬂip
angle: 90 degrees) with a resolution of 0.42 mm in plane
and slice thickness of 2.4 mm. Axial DWIs were obtained
(TE/TR: 4000/85 ms, ﬂip angle: 90 degrees) with a
resolution of 1.79 mm in plane and slice thickness of 0.56
mm. The voxel-wise ADC map was constructed using 2
DWIs with 2 b-values (0, 1000 s/mm2). The radiologists
annotated the ILs in the MR images during the diagnosis,
and the targeted biopsy was performed with the MRIdeﬁned lesions superimposed using the T2WI on the
transrectal ultrasound images. The ILs were delineated by
3 different clinicians from our institute with the reference
to both radiology and pathology reports for consistency.
Three data sets are traditionally used to build deep
neural network-based models. The training set is used to ﬁt
the model; the validation set provides an unbiased
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evaluation of model ﬁt in selecting model and tuning
model hyper-parameters, and the testing set provides an
unbiased evaluation in the ﬁnal model ﬁt. For prostate
segmentation, 54 public patients (1085 slices in total and
an average of 20.1  1.4 slices per patient) were randomly
selected as the training set. The model was validated using
12 public patients and tested using 12 public patients and
16 private patients, respectively. Compared with the prostate, ILs have more variance in shape, size, and location.
Thus, more patient samples were included in the testing set
to evaluate the robustness of the model performance on the
IL delineation. The model was trained using 45 public
patients (614 slices in total and an average of 13.6  2.4
slices per patient) and was validated with 10 public patients
and tested with 23 public patients and 42 private patients.
We also trained the model with mix cohorts of the same 45
public patients and 21 additional private patients (314
slices in total and an average of 15.0  5.3 slices per
patient) to compare the model performances.
The long dimension of T2 images was resized to 384,
and the short dimension was resized to keep the same
width-to-length ratio as the original image and padded by
pixels with zero value to extend to the same size of 384.
The ADC map was resampled using bilinear interpolation
and rigidly registered to T2WI using a software developed
in house. All images were normalized slice by slice before
having the histogram equalized. For prostate segmentation, we used T2WI only in training, validation, and
testing, as the prostate gland can be well-deﬁned by the
morphologic imaging. For IL segmentation, only the region of the prostate was analyzed that prostate patches
were cropped out based on the results of the prostate
segmentation. Coregistered ADC map and T2WI were
combined as the model inputs (the ﬁrst channel was T2WI
and the second one was the ADC map).

Segmentation of PCa using Mask R-CNN
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prostate gland within the pelvic region and false negative in
the apex and base regions of the prostate gland. To train the
model for prostate segmentation, a smallest rectangle area
covering the entire prostate gland to the maximum was
estimated based on the training set. Images with the prostate
gland were masked by the clinician’s contour and were
labeled as “prostate”; the remaining images were masked by
the rectangle area and were labeled as “nonprostate” during
training. For each slice, delineated contours by the model
were scored by the probability of being “prostate” or
“nonprostate,” and the highest scoring contour and its label
was regarded as the ﬁnal result. This signiﬁcantly decreased
the false-positive and false-negative rate.

Intraprostatic lesion segmentation

Figure 1 shows the 2D Mask R-CNN architecture used
in our paper. A detailed description of network architecture and implementation of the Mask R-CNN model is
provided in Appendix 1 (available online at https://doi.
org/10.1016/j.adro.2020.01.005). in the supplement.
Many models based on 3-dimensional (3D) CNNs14e16
are available for volumetric segmentation. However, we
found it difﬁcult to directly extend the Mask R-CNN
model to perform 3D prostate and IL segmentation as
training was highly resource intensive. Therefore, we
developed a method to extend the model to perform a
more efﬁcient volumetric segmentation.

Because prostate cancer is multifocal disease and it is
unknown how many ILs each patient has, we designed the
Mask R-CNN model to perform multifocal PCa segmentation and selected 5 top suspicious ILs for each patient, which is consistent with the procedure for MRIguided prostate biopsy. Each IL was located with a
bounding box and for probability of being a lesion. The
lesion then was delineated on each slice within the
bounding box. Because multiple ILs could be detected on
the same slice, we set a threshold to determine whether
these delineated lesions were represented separate entities
or the same lesion. When the dice similarity coefﬁcient
(DSC) of 2 contours was greater than 0.5, these 2 contours and their bounding boxes were uniﬁed into new
ones, and their probability scores were averaged. After
this step, contours on all slices were ranked by their
scores and the highest scoring contour was selected as a
seed contour. Next we only selected the contours on the
adjacent slices having the highest DSC with the seed
contour, and both the DSC and its score were expected to
be larger than the cutoff thresholds. The selected adjacent
contour was regarded as the new seed contour and was
used to ﬁnd its next superior/inferior adjacent lesion. This
process was iterated until all slices were traversed or no
adjacent contour could be identiﬁed. Then these selected
seed contours were combined together to deﬁne the IL
volume. Algorithm 1 (available online at https://doi.org/1
0.1016/j.adro.2020.01.005). in supplement describes the
deﬁnition of the most suspicious volumetric IL after
contour union in detail. The same procedure was repeated
to deﬁne the volume of the next IL until 5 suspicious
lesions were delineated in total. The cutoff threshold of
score and DSC were 0.7 and 0.41, respectively, which
were ﬁne-tuned on the validation set.

Prostate segmentation

Evaluation metrics

We found that 2-dimensional (2D) Mask R-CNN introduced false positive in superior/inferior slices beyond the

The metrics used to evaluate the model included the
DSC, 95th percentile Hausdorff distance (HD), sensitivity

Extension of the model into 3-dimensional space
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Figure 1 General Mask-RCNN network architecture used in our paper. Predeﬁned anchors with different scales at one location are
shown as purple bounding boxes on the input image. Cubes are represented by kernel size  kernel size  number of ﬁlters, above
branch is used for classiﬁcation, bottom branch is used for segmentation.

(Sens.), and speciﬁcity (Spec.). DSC (Equation 1) evaluates how well 2 binary sets match with a DSC of 1
representing a perfect match of prediction and contoured
mask. HD (Equation 2) measures how far apart 2 subsets
within a metric space are from each other. Sens. (Equation
4), also known as the true positive rate, measures the
proportion of actual positives that are correctly identiﬁed;
Spec. (Equation 3), also known as the true negative rate,
measures the proportion of actual negatives that are
correctly identiﬁed. We also deﬁned the agreement rate
(Equation 5) as a degree to which model’s segmentation
results concur with clinicians’ segmentation results. The
formulas for these metrics are shown below:
2 , < ytrue ; ypred >
DSC Z
< ytrue ; ytrue > þ < ypred ; ypred >

a˛A

b˛B

Agreement Z

dIL
cIL

ð5Þ

where dIL denotes the number of detected lesions having
DSC greater than 0.1 with lesions contoured by clinicians,
cIL denotes the number of lesions contoured by clinicians.

Results

ð1Þ

where ytrue is the ground truth contour, ypred is the model’s
contour.
HDðA; BÞ Z maxfminfdða; bÞgg

whereas TPIL and TNIL denote the total number of pixels
within the lesion and background, respectively. Pixels are
counted within the entire prostate. DSC was calculated
based on 3D volume for both prostate and lesion
segmentation.

ð2Þ

where a and b are points of sets A and B, respectively; and
dða; bÞ is the Euclidean distance between these points;
95th percentile HD says that 95% of minfdða;bÞgis below
b˛B
this amount. A is the ground truth contour, B is the
model's contour.
Spec: Z

DTNobject
TNobject

ð3Þ

Sens: Z

DTPobject
TPobject

ð4Þ

For prostate segmentation, DTPprostate and DTNprostate
denote the number of slices detecting and not detecting
the prostate, respectively; and TPprostate and TNprostate
denote the total number of slices truly containing the
prostate and not containing the prostate, respectively. In
addition, 161 positive and 73 negative slices were used in
the validation for cohort 1; 156 positive and 84 negative
slices in the testing for cohort 1; and 216 positive and 246
negative slices in the testing for cohort 2. For IL segmentation, DTPIL and DTNIL denote the number of pixels
in the detected lesion and background, respectively,

Results of prostate segmentation are shown in Table 1.
We selected the model that achieved the highest DSC on
validation patients and tested the model using both public
and private patients. DSC, 95 HD, Sens., and Spec. were
0.88  0.04, 6.05  2.39 (mm), 0.93, and 0.98,
respectively on validation patients; 0.86  0.04, 6.19 
2.38 (mm), 0.95, and 0.85, respectively on public testing
patients; and 0.82  0.05, 8.94  4.09 (mm), 0.95, and
0.90, respectively on private testing patients. Figure 2
shows a sample of prostate segmentation results on
T2WIs by clinician and Mask R-CNN.
Results of IL segmentation are shown in Table 2.
When training with public patients only, agreement, DSC
of detection, Sens., and Spec. were 80%, 0.62  0.17,
0.55  0.30, and 0.974  0.010 respectively on validation

Table 1
Evaluation

Results of prostate segmentation
DSC

95 HD (mm) Sens. Spec.

12 public
0.88  0.04 6.05  2.39
validation
patients
12 public testing 0.86  0.04 6.19  2.38
patients
16 private testing 0.82  0.05 8.94  4.09
patients

0.93

0.98

0.95

0.85

0.95

0.90

Abbreviations: DSC Z dice similarity coefﬁcient; Sens. Z sensitivity; Spec Z speciﬁcity.
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Figure 2 Prostate segmentation results on 3 slices of T2-weighted images from one patient. Ground truth by the clinician (top rows) is
shown with prostate contour and bounding box; mask region-based convolutional neural network prediction (bottom rows) is shown
with bounding box, prostate contour, and prediction class and score.

patients; 87%, 0.59  0.14, 0.63  0.28, and 0.964 
0.015, respectively on public testing patients; and 47%,
0.38  0.19, 0.22  0.24, 0.972  0.015, respectively on
private testing patients. When training with mix cohorts of
patients, the values were 90%, 0.64  0.11, 0.57  0.23,
and 0.980  0.009, respectively, on validation patients;
83%, 0.56  0.15, 0.50  0.28, and 0.969  0.016,
respectively on public testing patients; and 63%, 0.46
 0.15, 0.33  0.17, and 0.977  0.013, respectively, on
private testing patients. Figure 3 shows a sample of IL
segmentation results on T2WIs by clinician and Mask RCNN.

Table 2

To facilitate a more comprehensive and unbiased evaluation of the Mask R-CNN’s performance, we trained a 2D
U-Net and a 3D U-Net and calculated the DSCs of the
prostate contours using the same 12 testing patients used for
the prostate segmentation. DSCs were 0.85  0.03 and 0.83
 0.07 using 2D U-Net and 3D U-Net, respectively.

Discussion
Conventional research applied classic machine
learning and statistical graph models to prostate and IL

Lesion detection and segmentation results

Training

Evaluation

DSC of detection

45 public patients

10
23
42
10
23
21

0.62
0.59
0.38
0.64
0.56
0.46

45 public patients þ 21
private patients

public validation patients
public testing patients
private testing patients
public validation patients
public testing patients
private testing patients








0.17
0.14
0.19
0.11
0.15
0.15

Abbreviations: DSC Z dice similarity coefﬁcient; Sens. Z sensitivity; Spec Z speciﬁcity.

Agreement

Sens.

80%
87%
47%
90%
83%
63%

0.55
0.63
0.22
0.57
0.50
0.33








Spec.
0.30
0.28
0.24
0.23
0.28
0.17

0.974
0.964
0.972
0.980
0.969
0.977








0.010
0.015
0.015
0.009
0.016
0.013
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Figure 3 Lesion segmentation on 2 continuous slices from one patient from our institute, with 2 lesion identiﬁed and contoured (green
and red) on T2-weighted images. Ground truth by the clinician (left column) is shown with lesion contour and bounding box; prediction
of 2 agreed candidate lesions by the mask region-based convolutional neural network (right column) is shown with bounding box, lesion
contour, and prediction class and score.

segmentation. Neural networkebased models for prostate
and IL segmentation have only been developed during the
past 3 years and are still in need of signiﬁcant
improvements. We performed a literature review
(Table 3)17-35 of previous works as our baseline and
compared their experiment set ups and results to show the
potential of deep neural networks on prostate and IL
segmentation.
In this study, we provided an unbiased evaluation of
Mask R-CNN’s performance using an independent patient
cohort from our institution. For prostate segmentation, the
validation and testing results showed promise on the
PROSTATEx-2 Challenge data set. When using private
patients as an independent testing cohort, we observed
slightly decreased performance in the DSC, whereas
sensitivity and speciﬁcity remained equivalent (Table 1).
We hypothesized that this is due to variations in prostate
delineation among clinicians. Other possible explanations
include variations in image quality and small size of data
set. Although U-Net is a more elegant fully convolutional
network (FCN), it analyzes the entire image as for

segmentation. Mask R-CNN differs from this kind of
segmentation model in that it is based on region proposal
network, which selects regions of interest and then performs pixel-to-pixel segmentation using FCN on the
selected regions of interest. We provided an unbiased
comparison between U-Net and Mask R-CNN using the
same 12 public testing patients. We compared the DSC
calculated by 2D and 3D U-Net with one calculated by
the Mask R-CNN and concluded that Mask R-CNN
slightly outperformed both U-Nets in prostate segmentation. Mask R-CNN may work better in lesion segmentation than FCN owing to its ability to detect possible lesion
patches ﬁrst, instead of a direct pixel prediction.
The segmentation of ILs is challenging owing to the
small volume, prostate tissue heterogeneity, and the often
a subtle appearance of tumor, and this leads to interobserver variability in deﬁning the ground truth. We ﬁrst
explored differences between contours by 2 clinicians on
the same lesion in 19 patients. The DSC was sensitive to
the relative size of the target and was generally low in the
evaluation of IL segmentation. The DSC was 0.67  0.21,

Advances in Radiation Oncology: --- 2020
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Literature review of publications for the prostate and IL segmentation

Publication

Task

Result

Evaluation

Tian et al17

Prostate segmentation Graph cut

Method

DSC Z 87.0%  3.2%

Mahapatra and
Buhmann18
Guo et al19

DSC Z 0.81

Milletari et al20

Prostate segmentation Super pixel þ random
forests þ graph cut
Prostate segmentation Stacked sparse autoencoder þ deformable
segmentation
Prostate segmentation V-Net þ dice-based loss

MICCAI 2012 Promise12
challenge
MICCAI 2012 Promise12
challenge
66 T2WIs

DSC Z 0.869  0.033

Zhu et al21

Prostate segmentation Deeply supervised CNN

DSC Z 0.885

Yu et al14

Prostate segmentation Volumetric convolutional DSC Z 89.43%
neural network
Prostate segmentation Landmark-free AAM
DSC Z 88%  5%

Toth and
Madabhushi22
Liao et al23
Prostate segmentation Stacked independent
subspace
analysis þ sparse label
Vincent et al24 Prostate segmentation AAM
Klein et al25
Li et al26
Kohl et al27

Cameron et al28

Chung et al29

Artan et al30

Artan et al31
Artan et al32

Ozer et al33

Artan et al34

Liu et al35

DSC Z 0.871  0.042

DSC Z 86.7%  2.2%

Trained with 50 MRI scans
Test with 30 MRI scans
Trained with 77 patients
Tested with 4 patients
MICCAI 2012 Promise12
challenge
Tested with 108 studies
30 T2WIs

DSC Z 0.88  0.03

MICCAI 2012 Promise12
challenge
Prostate segmentation Atlas matching
Median DSC varied
Leave-one-out test with 50
between 0.85 and 0.88
clinical scans
Prostate segmentation RW
DSC Z 80.7%  5.1%
30 MR volumes
IL segmentation
Adversarial networks
DSC Z 0.41  0.28
Four-fold cross-validation
Sens. Z 0.55  0.36
on 55 patients with
Spec. Z 0.98  0.14
aggressive tumor lesions
IL detection
Morphology, asymmetry, Accuracy (Acc.) Z 87%  1% 13 patients
physiology and
Sens. Z 86%  3%
size model
Spec. Z 88%  1%
20 patients
IL segmentation
Radiomics-driven CRF
Sens. Z 71.47%
Spec.Z 91.93%
Acc. Z 91.17%
DSC Z 39.13%
21 patients
IL segmentation
Cost-sensitive support
Sens. Z 0.84  0.19
vector machine þ CRF Spec. Z 0.48  0.22
DSC Z 0.35  0.18
IL localization
RW
Sens. Z 0.51
10 patients
Jakkard Z 0.44
16 patients with lesions
IL segmentation
RW
Sens. Z 0.62  0.23
in peripheral zone only
Spec. Z 0.89  0.10
DSC Z 0.57  0.21
20 patients
IL segmentation
Relevance vector machine Spec. Z 0.78
Sens. Z 0.74
DSC Z 0.48
10 patients with lesions
IL segmentation
Cost-sensitive CRF
Sens. Z 0.73  0.25
in peripheral zone only
Spec. Z 0.75  0.13
Acc. Z 0.71  0.18
DSC Z 0.45  0.28
11 patients
IL segmentation
Fuzzy Markov
Spec. Z 89.58%
random ﬁelds
Sens. Z 87.50%
Acc. Z 89.38%
DSC Z 0.6222

Abbreviations: AAM Z active appearance models; CNN Z convolutional neural network; CRF Z conditional random ﬁeld; DSC Z dice similarity
coefﬁcient; IL Z intraprostatic lesions; MRI Z magnetic resonance imaging; RW Z random walker; T2WIs Z T2-weighted images; Sens. Z
sensitivity; Spec Z speciﬁcity.
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demonstrating high interobserver variability in deﬁning IL
boundaries by trained clinicians. The DSC of our model
was 0.59  0.14 when training and testing with the public
cohort, which was in the same order of the comparison
between clinicians’ performances. Most works28-35 on IL
segmentation were performed with less than 25 clinical
scans, and others32,34,35 focused on lesions in the
peripheral zone only. In our study, we validated and
tested the Mask R-CNN model to identify the ILs within
the entire prostatic gland using 75 clinical scans from both
public and private patient cohorts. To the best of our
knowledge, the highest performance was achieved by Liu
et al with DSC Z 0.6222, Sens. Z 87.50%, and Spec. Z
89.58%.35 However, they tested a small cohort of 11
patients, and the study was limited to the lesions in the
peripheral zone. We identiﬁed only one study applying
the neural networkebased model for IL segmentation27
with DSC Z 0.41  0.28, Sens. Z 0.55  0.36, and
Spec. Z 0.98  0.14. Similar to this study, we achieved
relatively low Sens. and high Spec. compared with the
classic models. There are 2 explanations of the performance of our model: (1) Spec. was calculated based on
the whole prostate volume instead of a single MRI slice,
leading to the high Spec.; (2) classic models predict more
false-positives, whereas Mask R-CNN predicts lesions
with size more close to a real lesion. This can potentially
facilitate PCa diagnosis and treatment (eg, dose-escalated
radiation therapy to the ILs). The performance of Mask RCNN dropped when training with patients from cohort 1
and testing with cohort 2. We hypothesize this was due to
the different acquisition parameters of the DWIs between
the 2 patient cohorts, which led to different data distributions between the 2 cohorts. The ADC maps were
created from 3 b values (50, 400, and 800 s/mm2) in
cohort 1, which were different from the 2 b values (0,
1000 s/mm2) in cohort 2. The variability of the signal
intensity values in ADC maps was reduced using the 3point b values.36 The model generalization is challenging considering MR acquisition and reconstruction
techniques are signiﬁcantly different along with different
types of scanners and imaging protocols. Recent research
has been working on developing generative models.37,38
We investigated how to improve the model generalization. We added a small number of the patient data from
cohort 2 and ﬁne-tuned the model using the mixture of
cohort 1 and cohort 2 patients. The results showed an
increase of the average value and a decrease of the variance of the DSC, Sens., and Spec. when testing with
cohort 2. The overall performance of the model was
improved, indicating that it was a viable solution to
generalize the model by ﬁne-tuning it with a small sample
size of an independent cohort.
Deﬁnitive radiation therapy for prostate cancer involves
treating the entire prostate gland with a homogeneous
dose. Newer studies suggest a local control beneﬁt with an
additional simultaneous integrated boost to the ILs using a
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number of different radiation therapy techniques (eg,
IMRT, SBRT, brachytherapy). It is in designing the
appropriate IL boost volume that auto segmentation may
add value by decreasing physician labor. Assuming physicians have adequate experience in mp-MRI interpretation, they must bring up multiple sequences of the mpMRI data set into the appropriate image viewer including,
at minimum, the T2-weighted and the diffusion-weighted
axial images, and scroll through the individual slices to
determine the site of the IL. The performance of IL segmentation in the present study may allow radiation oncologists to quickly determine whether or not they are in
agreement with the model prediction. The model prediction can also be served as the secondary check for quality
control. With a relatively high Dice coefﬁcient, the radiation oncologist may feel comfortable accepting the auto
segmentation. In cases where there is little to no agreement
between the physician and the auto segmentation
(including failure to delineate a target), it would also raise
the alarm for the clinician to carefully evaluate and justify
the manually delineated DIL contour.
As health care costs continue to rise at a rapid rate, there
is mounting pressure to cut costs and to improve efﬁciency.
Contouring is usually the single most time-consuming activity for a radiation oncologist, and advances in auto segmentation may make the process more efﬁcient. Overall, the
current performance of IL segmentation is not perfect, but it
does offer the possibility of augment a radiation oncologist
on the IL delineation. As more data are made available, we
may reasonably expect that the performance of IL segmentation will improve over time.

Conclusions
Our research framework is able to work as an end-to-end
system. It automatically segmented the prostate gland and
identiﬁed highly suspicious volumetric lesions within the
entire prostate directly from the clinical MRI scans without
human intervention, thereby demonstrating the potential to
assist the clinician in tumor delineation. Future research of
validating imaging ﬁndings with histopathologic images to
map spatial extend of tumor foci is warranted for accurate
delineation of ILs for radiation treatment.

Supplementary data
Supplementary material for this article can be found at
https://doi.org/10.1016/j.adro.2020.01.005.
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